1.Amitrano L, Guardascione MA, Brancaccio V, Margaglione M, Manguso F, Iannaccone L, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. JOURNAL OF HEPATOLOGY. 2004; 40:736–741.
2.Rodriguez-Castro KI, Porte RJ, Nadal E, Germani G, Burra P, Senzolo M. Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review. TRANSPLANTATION. 2012; 94:1145–1153.
3.Stine JG, Shah PM, Cornella SL, Rudnick SR, Ghabril MS, Stukenborg GJ, et al. Portal vein thrombosis, mortality and hepatic decompensation in patients with cirrhosis: A meta-analysis. World J Hepatol. 2015; 7:2774–2780.
4.Stine JG, Pelletier SJ, Schmitt TM, Porte RJ, Northup PG. Pre-transplant portal vein thrombosis is an independent risk factor for graft loss due to hepatic artery thrombosis in liver transplant recipients. HPB (Oxford). 2016; 18:279–286.
5.Shetty S, Ghosh K. Thrombophilic dimension of Budd chiari syndrome and portal venous thrombosis—a concise review. THROMBOSIS RESEARCH. 2011; 127:505–512.
6.Cagin YF, Bilgic Y, Berber I, Yildirim O, Erdogan MA, Firat F, et al. The risk factors of portal vein thrombosis in patients with liver cirrhosis. Experimental and Therapeutic Medicine. 2019; 17:3189–3194.
7.Stine JG, Wang J, Shah PM, Argo CK, Intagliata N, Uflacker A, et al. Decreased portal vein velocity is predictive of the development of portal vein thrombosis: A matched case-control study. LIVER INTERNATIONAL. 2018; 38:94–101.
8.Qi X, Han G, He C, Yin Z, Guo W, Niu J, et al. CT features of non-malignant portal vein thrombosis: a pictorial review. Clin Res Hepatol Gastroenterol. 2012; 36:561–568.
9.Berzigotti A, Garcia-Criado A, Darnell A, Garcia-Pagan JC. Imaging in clinical decision-making for portal vein thrombosis. Nat Rev Gastroenterol Hepatol. 2014; 11:308–316.
10.Rector WJ, Campra J, Ralls PW, Charms M. Utility and limitations of splanchnic venous ultrasonography in diagnosis of portal hypertension. JOURNAL OF CLINICAL ULTRASOUND. 1986; 14:689–696.
11.Dong G, Huang X, Jiang S, Ni L, Chen S. Simvastatin Mitigates Apoptosis and Transforming Growth Factor-Beta Upregulation in Stretch-Induced Endothelial Cells. Oxidative Medicine and Cellular Longevity. 2019; 2019:6026051.
12.van Bommel F, Berg T. Treatment of HBV related cirrhosis. LIVER INTERNATIONAL. 2013; 33 Suppl 1:176–181.
13.Lertpipopmetha K, Auewarakul CU. High incidence of hepatitis B infection-associated cirrhosis and hepatocellular carcinoma in the Southeast Asian patients with portal vein thrombosis. BMC GASTROENTEROLOGY. 2011; 11:66.
14.Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis. GASTROENTEROLOGY. 2019; 156:1582–1599.
15.Violi F, Lip GY, Cangemi R. Endotoxemia as a trigger of thrombosis in cirrhosis. HAEMATOLOGICA. 2016; 101:e162-e163.
16.Kinjo N, Kawanaka H, Akahoshi T, Matsumoto Y, Kamori M, Nagao Y, et al. Portal vein thrombosis in liver cirrhosis. World J Hepatol. 2014; 6:64–71.
17.Doggen CJ, Smith NL, Lemaitre RN, Heckbert SR, Rosendaal FR, Psaty BM. Serum lipid levels and the risk of venous thrombosis. Arterioscler Thromb Vasc Biol. 2004; 24:1970–1975.
18.Girleanu I, Trifan A, Cojocariu C, Dimache M, Singeap AM, Stoica O, et al. Platelet indices in patients with de novo portal vein thrombosis and liver cirrhosis. Rev Med Chir Soc Med Nat Iasi. 2013; 117:641–647.
19.Mikula T, Kozlowska J, Stanczak W, Sapula M, Rozyk A, Wiercinska-Drapalo A. Serum ADAMTS–13 Levels as an Indicator of Portal Vein Thrombosis. Gastroenterol Res Pract. 2018; 2018:3287491.
20.Villa E, Camma C, Marietta M, Luongo M, Critelli R, Colopi S, et al. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. GASTROENTEROLOGY. 2012; 143:1253–1260.
21.Zhang DL, Hao JY, Yang N. Value of D-dimer and protein S for diagnosis of portal vein thrombosis in patients with liver cirrhosis. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH. 2013; 41:664–672.
22.Zhang D, Hao J, Yang N. Protein C and D-dimer are related to portal vein thrombosis in patients with liver cirrhosis. J Gastroenterol Hepatol. 2010; 25:116–121.
23.Englesbe MJ, Kubus J, Muhammad W, Sonnenday CJ, Welling T, Punch JD, et al. Portal vein thrombosis and survival in patients with cirrhosis. Liver Transpl. 2010; 16:83–90.